A stool specimen is the one sample a clinic hands to a patient and gets back days later. By the time it reaches the bench, two things have already happened that determine whether the test can be run: the patient collected it correctly, and the clinic packaged it correctly. A laboratory will reject a specimen for a missing identifier or a damp outer bag far more often than it will reject one for the biology inside it.
That is why the collection kit matters more than it looks. It is the container, the scoop, the label and the transport bag working as a single system, and the rules that system has to satisfy are written differently in Canada and the United States. This article sets out what a stool sample is used for, what Public Health Ontario requires before it will accept one, and how the two countries' packaging frameworks compare.
What is a stool sample used for, and why does the kit change?
A stool specimen is not one test. The collection method follows the analyte, and a kit that is right for one test is wrong for the next.
| Test type | Container and preservative | Handling window | Notes for the clinic |
|---|---|---|---|
| Bacterial culture | Clean container, no preservative | Transport promptly, refrigerated | Fresh sample, minimal delay |
| Ova and parasites | Container with fixative, or fresh | Fresh sample handled quickly | Fixative vials follow their own label |
| C. difficile toxin | Clean container | Per laboratory instruction | Do not freeze unless instructed |
| Calprotectin | Clean container | Refrigerated | Avoid excess liquid |
| Occult blood | Test-specific card or device | Per device label | Diet and medication instructions apply |
| Molecular GI panel | Manufacturer's collection device | Per device label | Device and transport are one system |
Two consequences follow. First, the clinic cannot stock a single "stool kit" and assume it covers every order. Second, the patient instruction sheet has to name the analyte, because the handling window differs between a culture and a calprotectin sample.
What makes a stool specimen acceptable in Canada?
Public Health Ontario publishes the criteria its laboratories apply, and the list is short and specific. For an acceptable specimen: "The specimen packaging meets the minimum Federal Regulation - Transportation of Dangerous Goods packaging requirements, The specimen is not leaking," and "Specific testing criteria for analyses as outlined in the test information sheet."
Patient identification is the second half of the test. Public Health Ontario states that "Any critical specimen that does not meet the patient identifier acceptance criteria (e.g. missing, incomplete or conflicting identifiers on the specimen and/or requisition) will require a signed waiver by the submitting health care provider" before testing can proceed. In practice, a mismatch between the name on the container and the name on the requisition is a phone call, a delay and sometimes a repeat collection.
Transport has its own instruction. Public Health Ontario requires that "STAT samples must be shipped separately from routine specimens in a clearly marked package indicating 'STAT' and handled in accordance with the Canadian Biosafety Standards and shipped in accordance with the Transportation of Dangerous Goods Regulations." The underlying instrument is the Transportation of Dangerous Goods Regulations (SOR/2001-286), which is federal law and applies to the package, not to the clinic's intention.
The practical reading of that for a Canadian clinic is three checks before any specimen leaves the building: identifier matches on container and requisition, packaging meets the TDG minimum and is not leaking, and the specific test information sheet has been followed for that analyte. Public Health Ontario's own test information index is the place those per-analyte requirements live, and its kit and test ordering instructions set out how collection kits are obtained.
How does the US packaging framework compare?
The United States writes the packaging requirement as an explicit triple-package design. 49 CFR 173.199 states that "A Category B infectious substance must be packaged in a triple packaging consisting of a primary receptacle, a secondary packaging, and a rigid outer packaging," and adds that "Primary receptacles must be packed in secondary packaging in such a way that, under normal conditions of transport, they cannot break, be punctured, or leak their contents into the secondary packaging."
Canada reaches the same engineering outcome through a performance requirement — packaging that meets the TDG minimum and does not leak — rather than by naming three layers in the acceptance criteria. Both routes end in a leak-proof outer package, but a Canadian clinic reading only the acceptance criteria has to go to the TDG regulations to learn what the package must actually be.
| Item | Canada | United States |
|---|---|---|
| Governing instrument for transport | Transportation of Dangerous Goods Regulations, SOR/2001-286 | 49 CFR part 173, subpart E |
| How acceptancy is expressed | Acceptance criteria cite the TDG packaging minimum and no leakage | Explicit triple packaging: primary, secondary, rigid outer |
| Patient identifier | Missing, incomplete or conflicting identifiers can trigger a signed waiver | Identification required as a condition of testing |
| Laboratory oversight | Provincial licensing, e.g. the Laboratory and Specimen Collection Centre Licensing Act (R.S.O. 1990, c. L.1) in Ontario | CLIA certification under 42 CFR part 493 |
| Test complexity tiers | Provincial licence and accreditation scope | Waived, moderate complexity, high complexity |
| Sample collection device rule | Classification by intended use under the Medical Devices Regulations | 21 CFR 862.1675, blood specimen collection device, Class II |
The laboratory oversight row is the structural difference that surprises buyers. In the United States, 42 CFR 493.1 sets out "the conditions that all laboratories must meet to be certified to perform testing on human specimens under the Clinical Laboratory Improvement Amendments of 1988," and 42 CFR 493.5 sorts tests into "waived," "moderate complexity" and "high complexity." Canada has no single federal equivalent: laboratories are licensed and accredited within the provincial system. For a clinic choosing where to send a stool sample, that means the US question is "what is your CLIA certificate?" and the Canadian question is "which licence and accreditation do you hold?"
What does a stool collection kit contain, and what should the clinic check?
A workable kit has five parts, and dropping any one of them produces a rejection.
A clean, leak-proof container. The primary receptacle. It should close positively and hold the scoop without overfilling.
A scoop, spatula or integrated lid tool. Patients will not use a kit that requires a separate implement they do not have.
A label that leaves room for two identifiers. The patient's name and one more piece of identifying information, written in a way that survives a fridge and a courier bag.
A transport bag sized to the container. A bag that is too small gets stretched, and a stretched bag is a leaking bag.
An instruction sheet matched to the analyte. The handling window and the preservative decision belong on the sheet, not in a verbal handover at the desk.
The kit is one line in a specimen handling station that also carries 90 mL specimen containers for other analytes, UN3373 specimen transport bags that keep the paperwork separate from the sample, and a defined waste stream for the used collection material.
What should the patient instruction sheet actually say?
Four instructions cover the common failure modes, and each one prevents a specific rejection.
- Write the name on the container before collecting. A label written afterwards, over a damp surface, is the most common identifier failure.
- Do not add urine or water. Contamination changes the sample and can make a culture unreadable.
- Refrigerate unless the sheet says otherwise. Most bacterial and calprotectin samples want cold; fixative vials follow their own label.
- Return it inside the window on the sheet. A sample that arrives after the window on the sheet is a sample the laboratory has to make a decision about.
For a timed collection, the instruction sheet also needs a start and finish time. A 24-hour collection reported without times is a collection the laboratory cannot interpret, and the repeat falls on the clinic.
Why do kits get rejected, and what does the clinic control?
Three causes cover most rejections, and the clinic controls all three: packaging that leaks, an identifier that does not match the requisition, and a handling window that was missed. None of them are the patient's fault in a well-run practice, because each one is designed in or designed out at the point the kit is handed over.
A short bedside script does most of the work. Show the patient the container and the bag. Say which analyte the test is for. Point at the identifier line. Hand over the sheet. That is thirty seconds against a repeat collection, a courier trip and a delayed diagnosis.
Sources
- Public Health Ontario, Criteria for acceptance of specimens
- Public Health Ontario, Test information index
- Public Health Ontario, Kit and test ordering instructions
- Transportation of Dangerous Goods Regulations, SOR/2001-286
- 49 CFR 173.199, Category B infectious substances
- 42 CFR 493.1, Basis and scope of CLIA
- 42 CFR 493.3, Applicability
- 42 CFR 493.5, Categories of tests by complexity
- 21 CFR 862.1675, Blood specimen collection device
- Medical Devices Regulations, SOR/98-282
- Laboratory and Specimen Collection Centre Licensing Act, R.S.O. 1990, c. L.1
- CLSI, Order of blood draw tubes and additives
- WHO, Laboratory biosafety manual
- CCOHS, WHMIS and hazard communication
- FDA, Medical device classification database
- Public Health Ontario, Provincial guidance for cleaning, disinfection and sterilization in health care settings
- WHO, World report on vision
Ordering for a clinic, laboratory or care home? Wholesale and multi-site ordering covers account setup and case pricing, and the B2B wholesale collection lists the lines stocked for institutional buyers. Sites that also run an in-house sterilizer can start with the biological indicator 5-pack trial.
Related reading
- Stool Collection Kits: What the Clinic Hands Over and What the Lab Accepts
- Does TDG Apply to Specimen Collection in Canada? What Clinics Must Actually Do
- Ontario Laboratory Licensing: What the Laboratory and Specimen Collection Centre Licensing Act Requires
Frequently Asked Questions
What are the acceptance criteria for a stool specimen?
Public Health Ontario's criteria require that the packaging meets the minimum federal Transportation of Dangerous Goods packaging requirements, that the specimen is not leaking, and that the specific testing criteria in the test information sheet for that analyte have been met. Patient identifiers must also match between the specimen and the requisition.
What happens if the patient identifier is missing on a stool sample?
For a critical specimen, Public Health Ontario states that a specimen failing the patient identifier criteria, such as missing, incomplete or conflicting identifiers on the specimen or requisition, will require a signed waiver by the submitting health care provider before testing proceeds.
How should a stool sample be packaged for transport?
The package has to meet the Transportation of Dangerous Goods Regulations and must not leak. In the United States, 49 CFR 173.199 spells out the same outcome as a triple package: a primary receptacle, a secondary packaging and a rigid outer packaging, with the primary receptacle unable to break, puncture or leak into the secondary packaging under normal transport conditions.
Do Canada and the US license laboratories the same way?
No. US laboratories are certified under CLIA, with 42 CFR 493.1 setting the conditions and 42 CFR 493.5 sorting tests into waived, moderate complexity and high complexity categories. Canadian laboratories are licensed and accredited within the provincial system, for example under Ontario's Laboratory and Specimen Collection Centre Licensing Act.
Can a stool sample be collected at home?
Yes, for most analytes, and the clinic's job is to hand over a kit and a sheet that match the test ordered. Tests with a fixative vial follow their own label, and any test with a short handling window should be returned in person rather than held over a weekend.
Why was my stool sample rejected?
The three common causes are packaging that leaked, an identifier that did not match the requisition, and a handling window that was missed. All three are controlled by the kit the clinic hands over and the instructions given at the desk, not by the patient.
Does a stool collection kit need a medical device licence in Canada?
The device rules attach to the intended use of the product. In Canada, classification follows the Medical Devices Regulations and the contact and use rules in Schedule 1. In the United States, a blood specimen collection device is classified at 21 CFR 862.1675 as Class II, so a buyer can check a specific product against the FDA classification database.
CliniEco Medical supplies specimen containers, specimen transport bags, biohazard waste bags and the wider laboratory and clinic consumable lines described in this article. Health Canada MDEL #35334. This article is written for clinic, laboratory and procurement professionals and is not clinical guidance; collection method, analyte selection and result interpretation belong to the treating clinician and the receiving laboratory.
0 commentaire